Cardarine vs Testosterone
Limited Research vs FDA Approved
compatible Researched · 90% Cardarine is fully compatible with exogenous testosterone. It does not interfere with androgen receptor signaling, does not affect testosterone metabolism, and does not contribute to HPG axis suppression. The lipid-improving properties of Cardarine may partially offset the negative lipid effects of exogenous testosterone use.
Molecular Data
Cardarine Testosterone
Weight 453.50 Da 288.42 Da (base)
Half-life ~16-24 hours ~8 days (cypionate)
Type PPAR-delta agonist (C21H18F3NO3S2) Steroid hormone (C19H28O2)
Key Benefits
Cardarine
01 Dramatic increase in endurance capacity through enhanced fatty acid oxidation in skeletal muscle
02 Promotes fat loss by shifting metabolic fuel preference toward fatty acid utilization over glucose
03 Improves lipid profiles: increases HDL cholesterol, decreases LDL cholesterol, and lowers triglycerides
04 Non-hormonal mechanism -- does not suppress testosterone or require post-cycle therapy
05 No androgenic side effects (no hair loss, no prostate stimulation, no virilization in women)
06 Long half-life (16-24 hours) permits convenient once-daily oral dosing
07 May offset lipid disruption caused by SARMs or anabolic steroids when used in combination
Testosterone
01 Restoration of normal testosterone levels in hypogonadal men
02 Increased lean muscle mass and strength
03 Improved bone mineral density and reduced fracture risk
04 Enhanced libido, sexual function, and erectile quality
05 Improved mood, energy, motivation, and cognitive clarity
06 Reduction in body fat percentage, particularly visceral fat
07 Increased red blood cell production and oxygen-carrying capacity
08 Improved insulin sensitivity and metabolic health markers
Dosing Protocols
Cardarine
10-20 mg/day / Once daily (oral)
Testosterone
100-200 mg/week (TRT) / 1-2x per week (injectable)
TRT - Standard Replacement 100-200 mg/week 1-2x per week
TRT - Conservative Start 80-100 mg/week 2x per week (40-50 mg per injection)
TRT - Propionate Protocol 25-50 mg every other day Every other day or 3x per week
Performance Enhancement - Moderate 300-500 mg/week 2x per week
Performance Enhancement - Advanced 500-750 mg/week 2-3x per week
Side Effects
Cardarine
Headaches (typically transient, most common in the first week)
Mild gastrointestinal discomfort (nausea, loose stools, or stomach upset, usually dose-dependent and transient)
Testosterone
Acne and oily skin (increased sebum production via DHT)
Water retention and bloating (estrogen-mediated)
Mild mood changes (irritability, increased assertiveness)
Increased hematocrit and hemoglobin (erythrocytosis)
Testicular atrophy (suppression of LH/FSH from exogenous testosterone)
Injection site pain, redness, or irritation
Increased body hair growth
Mild elevation in blood pressure
Contraindications
Personal or family history of cancer (the rodent carcinogenicity data warrants extreme caution in individuals with elevated cancer risk)
Pregnancy or potential pregnancy
Breastfeeding
Pre-existing liver disease (limited safety data)
Individuals under 18 years of age
Prostate cancer (active or history of hormone-sensitive prostate cancer)
Breast cancer in males
Polycythemia (hematocrit above 54% at baseline)
Uncontrolled severe heart failure
Untreated severe obstructive sleep apnea
Desire for near-term fertility (without concurrent HCG/FSH)
Pregnancy or potential exposure to pregnant women (Category X)
Hypersensitivity to testosterone or any formulation components
Research Evidence
Cardarine Testosterone
Status Limited Research FDA Approved
References 5 studies 5 studies
Latest May 2017 June 2023
FDA Approved No Yes
This comparison is for educational and research purposes only. Consult a healthcare professional before use.